Kamada (KMDA) Prepaid Assets (2016 - 2025)
Kamada (KMDA) posted quarterly Prepaid Assets of $3.6 million for Q4 2025, down 5.82% year-on-year from $3.8 million in Q4 2024, and down 5.82% on a QoQ basis from $3.8 million in Q4 2024.
Kamada (KMDA) Prepaid Assets (2016 - 2025) Analysis & Trends
Kamada (KMDA) has reported Prepaid Assets for 10 consecutive years, with $3.6 million the latest figure, recorded in Q4 2025.
- Quarterly Prepaid Assets fell 5.82% year-over-year to $3.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.6 million (down 5.82% YoY) and the FY2025 annual result came in at $3.6 million, down 5.82% from the prior year.
- Prepaid Assets slipped to $3.6 million in Q4 2025 per KMDA's latest filing, from $3.8 million in the prior quarter.
- Over the last five years, Prepaid Assets for KMDA reached as high as $4.4 million in Q4 2023 and fell as low as $3000.0 in Q4 2022.
- A 5-year average of $3.2 million and a median of $3.8 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets tumbled 99.92% — and 2023, when it soared 146733.33%.
- Year by year, Prepaid Assets stood at $4.0 million in 2021, then slumped by 99.92% to $3000.0 in 2022, then surged by 146733.33% to $4.4 million in 2023, then retreated by 12.67% to $3.8 million in 2024, then declined by 5.82% to $3.6 million in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $3.6 million, $3.8 million, and $4.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.62 Mn |
| Dec 31, 2024 | 3.85 Mn |
| Dec 31, 2023 | 4.41 Mn |
| Dec 31, 2022 | 3,000.00 |
| Dec 31, 2021 | 3.99 Mn |
| Dec 31, 2020 | 2.11 Mn |
| Dec 31, 2019 | 1.24 Mn |
| Dec 31, 2018 | 1.09 Mn |
| Dec 31, 2017 | 822,000.00 |
| Dec 31, 2016 | 1.06 Mn |